Skip to main content

ERRATUM article

Front. Pharmacol., 16 December 2022
Sec. Pharmacology of Infectious Diseases
Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.1120032

Erratum: The OBTAINS study: A nationwide cross-sectional survey on the implementation of extended or continuous infusion of β-lactams and vancomycin among neonatal sepsis patients in China

This article is an erratum on:

  1. The OBTAINS study: A nationwide cross-sectional survey on the implementation of extended or continuous infusion of β-lactams and vancomycin among neonatal sepsis patients in China

    1. Read original article
Frontiers Production Office Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
The OBTAINS study: A nationwide cross-sectional survey on the implementation of extended or continuous infusion of β-lactams and vancomycin among neonatal sepsis patients in China

by Zhou P, Cheng Y, Cao G, Xing Y, Zhai S, Tong X and Yang K (2022). Front. Pharmacol. 13:1001924. doi: 10.3389/fphar.2022.1001924

Due to a production error, there was an error in the second Reviewer affiliation. Instead of “Yogan Khatri, Ann Arbor, United States”, it should be “Yogan Khatri, Cayman Chemical, United States”.

The publisher apologizes for this mistake. The original version of this article has been updated.

Keywords: extended infusion, continuous infusion, β-lactams, vancomycin, neonatal sepsis, cross-sectional survey

Citation: Frontiers Production Office (2022) Erratum: The OBTAINS study: A nationwide cross-sectional survey on the implementation of extended or continuous infusion of β-lactams and vancomycin among neonatal sepsis patients in China. Front. Pharmacol. 13:1120032. doi: 10.3389/fphar.2022.1120032

Received: 09 December 2022; Accepted: 09 December 2022;
Published: 16 December 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.